Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized three-arm trial of treatments for anal intraepithelial neoplasia in HIV-positive adults
NL-OMON25252Phase 4Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2008
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of imiquimod and fluorouracil in anal intraepithelial neoplasia (AIN) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Histological resolution of AIN and Relapse rate. Planned start Jan 2008; status: not yet recruiting.
02
Drugs
imiquimodfluorouracil
03
Conditions
anal intraepithelial neoplasia (AIN)
Beyond the preview
Go deeper on NL-OMON25252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25252.